If you have an albuterol inhaler in your medicine cabinet, then you might want to check out the voluntary recall just issued by the British pharmaceutical company, GlaxoSmithKline.
The drugmaker is recalling more than 590,000 albuterol inhalers because of a “possible risk that the affected inhalers could potentially not deliver the stated number of actuations,” spokesperson Juan Carlos Molina wrote in an email.
Three lots of Ventolin HFA 200D inhalers have been voluntarily recalled from hospitals, pharmacies, retailers and wholesalers in the United States. The affected lot numbers include: 6ZP0003, 6ZP9944 and 6ZP9848.
Albuterol is a bronchodilator that relaxes muscles in the airways and increases airflow to the lungs. When functioning properly, the metered-dose inhaler releases a fixed dose of medication in aerosol form. Albuterol inhalation is used to treat or prevent bronchospasm in people with reversible obstructive airway disease. It is also used to prevent exercise-induced bronchospasm.
The recall was classified as a class-2 recall, which means “the products might cause a temporary health problem, or pose only a slight threat of a serious nature,” according to the Food and Drug Administration.
It’s not a patient-level recall, but people with inhalers that are among the affected lots can contact GSK’s customer service center at 1-888-825-5249. If the devices are not relieving symptoms, patients should seek medical treatment right away.